Home /
The 9th webinar on Accessibility to Digital Technologies organized by the EPTRI Medical Devices Platform was held online on 8th April of 2025. Participants had the chance to learn more about the difficulties of the access to digital health technologies and will...
ESFRI, the European Strategy Forum on Research Infrastructures, is a strategic instrument to develop the scientific integration of Europe and to strengthen its international outreach. ESFRI has established a European Roadmap for research infrastructures (RIs) and...
We are very happy to announce that EPTRI is now a partner of EU Health Coalition. The EU Health Coalition is a multi-stakeholder initiative dedicated to driving change for a healthier Europe. The Coalition promotes a shared vision of health in Europe, based on...
The 8th webinar on Digital Technologies for Children and Young People (Adolescents) organized by the EPTRI Medical Devices Platform was held online on 5th November of 2024. Participants had the chance to learn more about several applications and platforms developed...
The 7th webinar on Neonatal Technologies organized by the EPTRI Medical Devices Platform was held online on 17th September of 2024. In this webinar, which was a satellite event of the European Biotech Week, participants had the chance to learn more about the...
EPTRI has been implementing a Gender Equality Plan for 2024-2026, included in EPTRI’s Equality, Diversity and Inclusion strategy. This reaffirms its alignment with the 2030 Agenda and the Sustainable Development Goals. The Plan consists of 12 focus areas which aim...
We are happy to announce that our General Assembly and Scientific Meeting held on 18 and 19 of July in Bari, Italy and online were a success! We counted with about 250 participants both in person and online that learned about EPTRI's evolution story from a European...
The 6th webinar on Child Health Data and Artificial Intelligence organized by the EPTRI Medical Devices Platform was held online on 25th June of 2024. Participants had the chance to learn more about the impact of partnerships and co-design in shaping child health...
We are happy to announce our collaboration with Biogenera in their multi-center phase 1 clinical trial for the new orphan drug BGA002, intended for the treatment of aggressive pediatric tumors associated with alterations in the MYCN tumor gene. BIOGENERA has...
Our president, Karel Allegaert, participated in the paediatric committee (PDCO) scientific meeting related to the Belgian presidency that was held last week in Leuven. Related to the ongoing revision of the EMA guideline on neonatal clinical studies, Karel discussed...